Participant | Gender | Age | Primary diagnosis | Secondary diagnoses | Current medications | Past medication trials |
---|---|---|---|---|---|---|
1 | F | 22 | AN, restricting type | MDD, moderate, recurrent GAD | Venlafaxine ER 300 mg PO QAM for mood Temezapem 15–30 mg PO QHS PRN for insomnia | Fluoxetine Sertraline Bupropion Fluvoxamine Risperidone |
2 | F | 28 | BN | MDD, severe, recurrent PTSD | Fluvoxamine 100 mg QAM and 200 mg QHS for mood/anxiety Gabapentin 300 mg PO three times a day (TID) for anxiety Aripiprazole 5 mg PO QAM for mood Trazodone 100–150 mg PO QHS PRN for insomnia | Aripiprazole Fluvoxamine Gabapentin Trazodone Fluoxetine Prazosin |
3 | F | 43 | AN, restricting type | MDD, severe, recurrent GAD | Alprazolam 0.25–0.5 mg PO QD PRN for anxiety Buspirone 30 mg PO QAM for anxiety Desvenlafaxine 50 mg PO QAM for depression Quetiapine 12.5–25 mg PO QHS PRN for insomnia | Desvenlafaxine Alprazolam Fluoxetine Quetiapine Buspirone |
4 | F | 37 | AN, binge-purge type | MDD, severe, recurrent GAD | Aripiprazole 10 mg PO QHS for mood, clonazepam 0.5 mg PO QD PRN for anxiety Duloxetine 90 mg PO QAM for depression Lamotrigine 100 mg PO BID for mood Modafinil 100 mg PO QAM for depression Prazosin 2 mg PO QHS for PTSD Temazepam 15–30 mg PO QHS PRN for insomnia | Aripiprazole Clonazepam Duloxetine Lamotrigine Temazepam Modafinil |
5 | F | 31 | AN, restricting type | MDD, severe, recurrent PTSD | Aripiprazole 15 mg PO QHS for mood clonazepam 0.5–1 mg PO QD PRN for anxiety Duloxetine 120 mg PO QHS for depression Prazosin 5 mg PO QHS for PTSD Propranolol 5–10 mg PO BID PRN for anxiety Temazepam 15–30 mg PO QHS PRN for insomnia | Aripiprazol Duloxetine Clonazepam Prazosin Propanolol, temazepam Zolpidem Lamotrigine Quetiapine |